Bridge the Gap (BTG) - Black Youth Group
Bridge the Gap
Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide
1 other identifier
interventional
16
1 country
1
Brief Summary
The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:
- To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support. Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
March 18, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
April 30, 2026
April 1, 2026
1.6 years
March 12, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)
An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.
From pre-treatment until 3 months post-treatment, approximately 23 weeks.
Ethnic Identity Scale (EIS)
A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.
From baseline until 3 months post-treatment, approximately 22 weeks.
Living Ladder Scale
A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.
From baseline until 3 months post-treatment, approximately 22 weeks.
Brief Suicide Cognitions Scale (B-SCS)
A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.
From baseline until 3 months post-treatment, approximately 22 weeks.
Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)
A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.
From baseline until 3 months post-treatment, approximately 22 weeks.
Optimism and Hope Scale (OHS)
A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.
From baseline until 3 months post-treatment, approximately 22 weeks.
Parent Readiness for Hospital Discharge Scale (RHDS)
A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.
From baseline until 3 months post-treatment, approximately 22 weeks.
Group Cohesion Scale
A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.
From baseline until the beginning of post-treatment, approximately 10 weeks.
Study Arms (1)
Treatment Arm
EXPERIMENTALParticipants will complete a 10-week group and complete pre-treatment and post-treatment assessment measures.
Interventions
Participants will complete a group intervention, rooted in the Collaborative Assessment \& Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.
Eligibility Criteria
You may qualify if:
- years old
- Identify as Black or African American or being of African descent
- Have current suicidal ideation or suicidal ideation within the last 30 days
- Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.
You may not qualify if:
- An active psychotic disorder or current psychosis symptoms
- No history of suicide attempt(s) or suicide ideation in the past 30 days
- Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF \& SSP
- Caregivers, guardians, and/or the patient refuse to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American Psychological Foundationcollaborator
- Children's Hospital Los Angeleslead
Study Sites (1)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tia Tyndal, PhD
Children's Hospital Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator, Licensed Clinical Psychologist
Study Record Dates
First Submitted
March 12, 2025
First Posted
March 18, 2025
Study Start
June 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share